Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R. Barnes, Hélène Schuster, Munaza Ahmed et al.|Genetics in Medicine|2020Cited by 145
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancerManuel A. R. Ferreira, Jackie Cook, Eric R. Gamazon et al.|Nature Communications|2019Cited by 138
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Ana Osório et al.|Genetics in Medicine|2017Cited by 93
Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathyJacopo Azzollini, Lidia Larizza|Journal of Human Genetics|2014Cited by 15